Institutional Ownership
Rani Therapeutics Hldgs Inc
CUSIP 753018100COM CL ARANIQ1 2026
13D / 13G Filings
20
Schedule 13D/13G on record
Beneficial Filers
14
Distinct reporting persons
Largest Stake
62.6%
Max % of class reported
Institutional Holders
70
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
20 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Awm Investment Company, Inc. | 13G | 9.9% | 9.75M | SEC |
| 2 | Jan 30, 2026 | The Vanguard Group | 13G | 5.2% | 5.11M | SEC |
| 3 | Oct 30, 2025 | Samsara Biocapital, L.P. | 13D | 9.9% | — | SEC |
| 4 | Oct 30, 2025 | Ra Capital Management, L.P. | 13G | 9.9% | 9.88M | SEC |
| 5 | Oct 27, 2025 | Incube Labs, L.L.C. | 13D/A | 22.1% | — | SEC |
| 6 | Oct 23, 2025 | Invus Public Equities, L.P. | 13G | 10.0% | 9.83M | SEC |
| 7 | Oct 22, 2025 | South Cone Investments Limited Partnership | 13D/A | 4.9% | — | SEC |
| 8 | Aug 15, 2025 | Armistice Capital, LLC | 13G/A | 9.9% | 6.26M | SEC |
| 9 | Jul 23, 2025 | Orca Capital AG | 13G/A | 4.3% | 1.89M | SEC |
| 10 | Jul 17, 2025 | Orca Capital AG | 13G | 9.9% | 4.35M | SEC |
10 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Rani Therapeutics Hldgs Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 8.50M | $6.25M |
| 2 | Samsara Biocapital, LLC | 8.50M | $6.25M |
| 3 | Awm Investment Company, Inc. | 6.50M | $4.78M |
| 4 | Symbiosis Capital Partners, LLC | 3.67M | $2.69M |
| 5 | Longaeva Partners L.P. | 2.33M | $1.71M |
| 6 | Siren, L.L.C. | 2.00M | $1.47M |
| 7 | Geode Capital Management, LLC | 903.3K | $664.1K |
| 8 | Blackrock, Inc. | 556.9K | $409.2K |
| 9 | Nan Fung Group Holdings Ltd | 493.6K | $362.7K |
| 10 | 683 Capital Management, LLC | 487.2K | $358.0K |